NEW YORK (GenomeWeb) – Japan's Central Social Insurance Medical Council this week approved a recommendation from the country’s Ministry of Health, Labor, and Welfare to reimburse for Luminex’s Gram-Positive Blood Culture test and the Gram-Negative Blood Culture test. Reimbursement for the two tests by MHLW went into effect on June 1. Japan’s Pharmaceuticals & Medical Devices Agency cleared the panels in 2016.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.